Last update :
18/04/2024
Anticancer drug   Cetuximab  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Erbitux Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Hungary, Iceland, India, Iran, Ireland, Italy, Japan, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Republic of South Africa, Romania, Spain, Sweden, Switzerland, Turkey, United States of America, Venezuela
Stability in solutions   Injection   Stability in solutions : Cetuximab     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass None 5 mg/ml -20°C Light
72 Hour
2220
Manufacturer's stability data

Glass None 5 mg/ml 2-8°C Light
1461 Day
2220
Manufacturer's stability data

Glass None 5 mg/ml 25°C Light
72 Hour
2220
Manufacturer's stability data

Partially used vials None 5 mg/ml 25°C Not specified
3 Day
4755
Level of evidence A+

Polyvinyl chloride Sodium chloride 0,9% 0.45 >> 5 mg/ml 25°C Light
48 Hour
2220
Manufacturer's stability data

Polyethylene Sodium chloride 0,9% 0.45 >> 5 mg/ml 25°C Light
48 Hour
2220
Manufacturer's stability data

Polypropylene Sodium chloride 0,9% 0.45 >> 5 mg/ml 25°C Light
48 Hour
2220
Manufacturer's stability data

Polypropylene None 5 mg/ml 25°C Not specified
3 Day
4755
Level of evidence A+

Polypropylene None 5 mg/ml 4°C Not specified
90 Day
4755
Level of evidence A+

Polyolefine Sodium chloride 0,9% 1 mg/ml 25°C Not specified
3 Day
4755
Level of evidence A+

Polyolefine Sodium chloride 0,9% 1 mg/ml 4°C Not specified
90 Day
4755
Level of evidence A+

Ethylene vinyl acetate Sodium chloride 0,9% 0.45 >> 5 mg/ml 25°C Light
48 Hour
2220
Manufacturer's stability data


  Mentions Légales